Biochemical Characterisation and Localization in Brain of a Human Brain‐Leucocyte Membrane Glycoprotein Recognised by a Monoclonal Antibody

Abstract

The F10‐44‐2 monoclonal antibody was originally shown to interact with a determinant found predominantly in human brain and leucocytes. In this study we demonstrate by quantitative absorption analysis with homogenates of the head of the caudate nucleus, putamen, thalamus, cerebral grey matter, cerebral white matter, corpus callosum and cerebellar folia that the determinant is restricted to the white matter of the CNS. Immunofluorescence studies on frozen sections of the above brain subregions confirm the absorption analyses, showing staining only of white matter. In addition, and unexpectedly, we found very bright staining around blood vessels, particularly in the cerebellum. Biochemical studies established that the molecule in white matter bearing the F10‐44‐2 determinants is a sialylated membrane glycoprotein with an apparent molecular weight of 90,000, which is similar to but slightly smaller than the T lymphocyte form of the antigen. Developmental studies comparing 16‐week foetal and adult cerebrum showed a fivefold increase in F10‐44‐2 antigen content. Thus, in the human CNS, the F10‐44‐2 antigen is a medium‐sized glycoprotein which is restricted to white matter and shows a marked increase in concentration during development. No such molecule has been described previously.